arrow
E

Emanuele Spina

Autonomous University of Madrid
H指数:18
被引数:1,226

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Haemorrhagic Transformation in Breakthrough Ischemic Stroke: Clinical Characteristics, Outcomes, and Anticoagulation Resumption Timing—Insights from the ASPERA-R Study

突破性缺血性卒中中的出血转化:临床特征、结局和抗凝恢复时机——ASPERA-R研究的启示

2026-11-030
PRE
Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysis

心房颤动口服抗凝患者突破性缺血性卒中后,后循环与前循环梗死部位的比较及预后:一项ASPERA-R逆概率加权分析

2026-09-290
PRE
Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study

尽管正在接受口服抗凝治疗,仍发生缺血性卒中的病因解读及其临床影响:ASPERA-R研究

2026-08-170
OAAI
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study

早期与晚期开始直接口服抗凝剂治疗突破性缺血性卒中:一项来自ASPERA-R研究的靶向试验分析

2026-06-190
PRE
Rituximab versus placebo for chronic inflammatory demyelinating polyradiculoneuropathy: a randomized trial

利妥昔单抗对比安慰剂治疗慢性炎症性脱髓鞘性多发性神经根神经病:一项随机试验

BRAIN
IF11.7
2024-12-102
PRE
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy
2023-04-045
PRE
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy
2022-09-0816
OA
Digital work engagement among Italian neurologists
2021-07-208
OAAI
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy
2020-08-3120
OAAI
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype
2020-01-01126
OAAI